Algorithm-based Management to Reduce the Recurrence of GI Bleeding and Severe Epistaxis in Von Willebrand Disease | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Algorithm-based Management to Reduce the Recurrence of GI Bleeding and Severe Epistaxis in Von Willebrand Disease	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Epistaxis, Gastrointestinal Hemorrhage, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, angiodysplasia, blood coagulation disease, blood platelet disease, cardiovascular disorder, coagulation protein disease, digestive system disorder, hematologic disorder, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, vascular disorder, von Willebrand disease (hereditary or acquired)	Recruiting	Not applicable	2026-05-18		NCT06651255

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University Hospital, Lille	194

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
AP-HM Hôpital Timone	Marseille	France	1
AP-HP Hôpital Kremlin Bicetre	Le Kremlin-Bicêtre	France	1
CH Chambery	Chambéry	France	1
CHRU Brest	Brest	France	12
CHU Amiens	Amiens	France	7
CHU Caen	Caen	France	13
Chu Clermont-Ferrand	Clermont-Ferrand	France	19
Chu Dijon	Dijon	France	14
CHU Lille	Lille	France	2
CHU Montpellier	Montpellier	France	8
CHU Nantes	Nantes	France	26
CHU Rennes	Rennes	France	21
CHU Rouen	Rouen	France	8
CHU Strasbourg	Strasbourg	France	9
Chu Toulouse	Toulouse	France	4
CHU Tours	Tours	France	1
Hôpital cardiologique Louis Pradel	Bron	France	2